Adipose Derived Stromal Vascular Fraction and Mesenchymal Stem Cells Improve Angiogenesis in a Rat Hindlimb Ischaemia Model

Abstract

Objective: This study aimed to investigate the effect of human adipose tissue derived stromal vascular fraction (AD-SVF) and mesenchymal stem cells (AD-MSCs) on blood fl ow recovery and neovascularisation in a rat hindlimb ischaemia model. Methods: SVF was isolated using an automated centrifugal system, and AD-MSCs were obtained from adherent cultures of SVF cells. Rats were divided into four groups of six rats each: non-ischaemia (Group 1); saline treated ischaemia (Group 2); SVF treated ischaemia (Group 3); and AD -MSC treated ischaemia (Group 4). Unilateral hindlimb ischaemia was induced in Sprague - Dawley rats via femoral artery ligation. Saline, SVF, or AD-MSCs were injected intramuscularly into the adductor muscle intra-operatively. Cell viability was calculated as the percentage of live cells relative to total cell number. Blood fl ow improvement, muscle fi bre injury, and angiogenic properties were validated using thermal imaging and histological assessment. Results: The viabilities of SVF and AD-MSCs were 83.3% and 96.7%, respectively. Group 1 exhibited no signi fi cant temperature difference between hindlimbs, indicating a lack of blood fl ow changes. The temperature gradient gradually decreased in SVF and AD -MSC treated rats compared with saline treated rats. In addition, only normal muscle fi bres with peripherally located nuclei were observed in Group 1. Groups 3 and 4 exhibited signi fi cantly fewer centrally located nuclei, indicating less muscle damage compared with Group 2. Regarding angiogenic properties, CD31 staining of endothelial cells showed similar patterns among all groups, whereas expression of vascular endothelial growth factor, as a crucial angiogenesis factor, was enhanced in the SVF and AD -MSC treated groups. Conclusion: SVF and AD-MSCs improved blood fl ow and neovascularisation in a rat hindlimb ischaemia model, suggesting their potential ability to promote angiogenesis. Further extensive research is warranted to explore their potential applications in the treatment of severe lower extremity arterial disease.